Evaluation of rheumatologists’ knowledge of biosimilars
Abstract Introduction Biosimilars reduce the cost of biologic therapy without compromising safety and effectiveness. In this study we evaluated Brazilian rheumatologists’ knowledge and perceptions of biosimilars. Methods Cross-sectional and descriptive study based on a questionnaire containing 17 it...
Saved in:
| Main Authors: | Thayane Furtado Rolim Lima, Lia Poti Gomes Cordeiro, Kirla Wagner Poti Gomes, Carlos Ewerton Maia Rodrigues |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Advances in Rheumatology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42358-025-00465-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosimilars, the journey has begun
by: Alba Martos-Rosa, et al.
Published: (2015-01-01) -
Safety of Switching from a Reference Biologic to Its Biosimilar: A Systematic Review and Meta-Analysis
by: Sarah Saad Aljahili, et al.
Published: (2025-02-01) -
Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma Patients
by: Tamather Almandeel, et al.
Published: (2025-06-01) -
Biologics and biosimilars in musculoskeletal diseases: addressing regulatory inconsistencies and clinical uncertainty
by: Lauren N. McGrath, et al.
Published: (2025-07-01) -
Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers
by: Fernando Perez-Ruiz, et al.
Published: (2024-09-01)